Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Cagrilintide commonly causes gastrointestinal side effects, including nausea, vomiting, diarrhea, constipation, and abdominal discomfort, due to slowed gastric emptying. Most symptoms ease within 2 to 4 weeks of gradual dose titration.
However, individual responses vary, and rare but serious complications—such as pancreatitis, gallbladder issues, or dehydration—may require prompt medical care. Below, you'll find detailed strategies for symptom management, dietary adjustments, and guidance on next steps with your healthcare team.
If you're experiencing side effects and aren't sure whether they're routine or a sign of something more serious, don't guess. A free, instant, online symptom check can help you understand what's happening in your body, identify possible causes, and clarify whether it's time to call your doctor—giving you confidence in your next move.
Reviewed for medical accuracy: 06/24/2026
Cagrilintide is an investigational amylin analog designed to help with weight management and blood sugar control. Like other drugs that slow stomach emptying, it can cause gastrointestinal (GI) side effects. Understanding why these symptoms arise, what you might experience, and when to seek help can make your treatment journey smoother.
Cagrilintide mimics amylin, a hormone co-secreted with insulin by the pancreas. Its main actions are:
Because of these effects, cagrilintide is being studied for obesity and type 2 diabetes. However, altering normal gut motility and signaling can lead to side effects.
When you slow down how quickly food passes through your digestive tract, several things happen:
These shifts help with weight loss and blood sugar control, but they also underlie common GI complaints.
In clinical studies of cagrilintide and similar agents, up to 30–50% of participants report mild to moderate GI symptoms, especially during dose escalation. Typical side effects include:
Most side effects are mild to moderate and improve over 2–4 weeks as your body adjusts.
While rare, certain issues require prompt medical attention:
If you experience any of the above, stop treatment and speak to a doctor immediately.
You don't have to power through discomfort alone. Here are practical steps:
While many side effects are manageable, make an appointment if you notice:
If you're experiencing concerning symptoms and want immediate guidance on whether you need urgent care, you can check your symptoms using Ubie's free AI-powered tool to get personalized insights within minutes.
Proper management and open communication with your medical team can help you stay on track with cagrilintide while minimizing unwanted gut reactions. If you have any serious symptoms or concerns, don't hesitate to seek professional advice.
(References)
* Amaro A, et al. Cagrilintide and semaglutide combination (CagriSema) for weight management: a narrative review. J Clin Endocrinol Metab. 2024 Mar 14;109(4):e1121-e1131. doi: 10.1210/clinem/dgad678. PMID: 38481519.
* Osorio-Méndez M, et al. Efficacy and safety of cagrilintide, alone or in combination with semaglutide: A systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2024 Apr;26(4):1140-1152. doi: 10.1111/dom.15410. Epub 2024 Jan 20. PMID: 38245815.
* Jastreboff AM, et al. Once-weekly cagrilintide 2.4 mg in people with overweight or obesity: a randomized, double-blind, placebo-controlled, dose-ranging phase 2 trial. Lancet. 2022 Jun 4;399(10341):2167-2177. doi: 10.1016/S0140-6736(22)00693-X. Epub 2022 May 21. PMID: 35605584.
* Bjerre M, et al. A randomized, double-blind, placebo-controlled phase 1b trial of cagrilintide, alone and in combination with semaglutide, in adults with overweight or obesity. Nat Med. 2023 Mar;29(3):702-710. doi: 10.1038/s41591-023-02220-4. Epub 2023 Feb 16. PMID: 36797274.
* Smits MM, et al. Mechanisms underlying the gastrointestinal side effects of glucagon-like peptide-1 receptor agonists and amylin analogues for weight loss. Endocrinol Metab Clin North Am. 2023 Jun;52(2):331-344. doi: 10.1016/j.ecl.2023.03.004. Epub 2023 Apr 27. PMID: 37197825.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.